BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED

Bloomage BioTechnology Corporation Limited

688363

CNE100003NL9

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 09/05/2024 BST			5-day change	1st Jan Change
62.3 ^CNY	-1.46%		+1.30%	-6.92%

04-29	Bloomage BioTechnology Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-02	Tranche Update on Bloomage BioTechnology Corporation Limited's Equity Buyback Plan announced on August 17, 2023.	CI

Bloomage BioTechnology Corporation Limited(SHSE:688363) dropped from Shanghai Stock Exchange Health Care Sector Index

June 10, 2022 at 05:00 am

Bloomage BioTechnology Corporation Limited has been dropped off from Shanghai Stock Exchange Health Care Sector Index .

Latest news about Bloomage BioTechnology Corporation Limited

Bloomage BioTechnology Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Tranche Update on Bloomage BioTechnology Corporation Limited's Equity Buyback Plan announced on August 17, 2023.	04-01	CI
Bloomage Biotech Names CFO	02-29	MT
Bloomage Biotechnology's 2023 Profit Falls 39.5%; Misses EPS Estimates	02-29	MT
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023	02-28	CI
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23	CI
Bloomage Buys Back 8.4 Million Yuan Shares	05/10/23	MT
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23	CI
Bloomage BioTechnology Corporation Limited announces an Equity Buyback for CNY 300 million worth of its shares.	17/08/23	CI
Bloomage BioTechnology Corporation Limited authorizes a Buyback Plan.	16/08/23	CI
Chinese company earnings reveal lopsided economic recovery	10/05/23	RE
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	29/04/23	CI
Bloomage Biotech Showcases Cutting-Edge Bioactive Ingredients at International Consumer Products Expo, Expands Global Reach	18/04/23	CI
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23	CI
Yongtaiyun Chemical Logistics to Buy Local Chemical Producer For 50 Million Yuan	13/02/23	MT
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the Nine Months Ended September 30, 2022	28/10/22	CI
Bloomage BioTechnology Corporation Limited(XSSC:688363) added to S&P Global BMI Index	19/09/22	CI
Bloomage Biotechnology to Absorb, Merge With Subsidiary	30/08/22	MT
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2022	20/07/22	CI
Bloomage BioTechnology Corporation Limited(SHSE:688363) dropped from Shanghai Stock Exchange Health Care Sector Index	10/06/22	CI
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	25/04/22	CI
Bloomage BioTechnology Corporation Limited, entered into a property rights transaction contract to acquire 51% of Beijing Yierkang Bioengineering Co., Ltd., for CNY 233 million.	19/04/22	CI
Bloomage BioTechnology Corporation Limited(XSSC:688363) added to FTSE All-World Index	21/03/22	CI
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2021	25/02/22	CI
Bloomage BioTechnology Corporation Limited(SHSE:688363) added to Shanghai Stock Exchange 180 Value Index	13/12/21	CI

Chart Bloomage BioTechnology Corporation Limited

Duration

Period

Chart Bloomage BioTechnology Corporation Limited

More charts

Bloomage Biotechnology Corp Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of hyaluronic acid and other bioactive products. The Company's products include raw material products, medical end products, functional skin care products and functional foods. The raw material products include a series of bioactive products with hyaluronic acid as the core, which are widely used in the fields of drugs, medical devices, cosmetics, functional food and general food. The medical end products are divided into medical beauty and medicine, including ophthalmic viscoelastics, medical lubricants, soft tissue fillers, medical skin protectors and others. The functional skin care products include lotion, cream, facial mask, hand mask and others. The functional foods include hyaluronic acid water, hyaluronic acid food and others.

Sector

Pharmaceuticals

Calendar

26/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Bloomage BioTechnology Corporation Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

62.3 CNY

Average target price

72.07 CNY

Spread / Average Target

+15.68%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Biopharmaceuticals

	1st Jan change	Capi.
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED	-6.92%	4.13B
CSL LIMITED	-2.61%	89.08B
SAMSUNG BIOLOGICS CO.,LTD.	+3.55%	40.9B
BIOGEN INC.	-14.40%	32.25B
UCB	+55.89%	25.14B
BIOMARIN PHARMACEUTICAL INC.	-15.96%	15.39B
INCYTE CORPORATION	-15.50%	11.91B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-41.29%	11.89B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11.75%	11.64B
SWEDISH ORPHAN BIOVITRUM AB	+7.87%	9.03B

Biopharmaceuticals